Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.Cmvv_fHs.js ...

Kohl’s Corp (NYSE:KSS) shares are trading lower after the company reported third-quarter earnings. The company reported a net ...

Kohl's on Tuesday forecast a bigger drop in annual sales than previously expected, a sign the department-store chain is ...

Kohl’s saw sales decline in the latest quarter while its revised outlook for the year suggested a challenging upcoming ...

Kohl's shares are sinking in premarket trading after the department store chain reported weaker-than-expected results and lowered its guidance, and said that chief executive Tom Kingsbury is stepping ...

Ashley Buchanan, CEO of Michaels Companies will become the new CEO on Jan. 15, Kohl’s announced. He has been CEO of Michaels ...

Kohl's reported disappointing Q3 earnings as sales in key segments lagged expectations, prompting a downward revision of its ...

Kohl’s (KSS) slid over -4% in pre-market trading after the company said in a statement that CEO Tom Kingsbury will resign effective January 15th, 2025. Chevron (CVX) gained more than +1% in pre-market ...

Kohl’s Corporation’s outgoing CEO Tom Kingsbury said in a Tuesday media release that third quarter results did not meet ...

Kohl’s Corporation is reporting that company CEO Tom Kingsbury plans to step down as CEO, effective January 15, 2025. He will ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the proposal.